Suppr超能文献

作为新型利钠肽受体1(NPR1)激活剂的氢喹唑啉衍生物

Hydroquinazoline Derivatives as Novel Natriuretic Peptide Receptor 1 (NPR1) Activators.

作者信息

Zhou Xin, Liang Steven H

机构信息

Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.

出版信息

ACS Med Chem Lett. 2025 Jan 23;16(3):358-360. doi: 10.1021/acsmedchemlett.5c00013. eCollection 2025 Mar 13.

Abstract

This patent highlights hydroquinazoline compounds and their pharmaceutically acceptable salts, as well as compositions and methods of preparation. The compounds in this invention were evaluated for their potency on Natriuretic Peptide Receptor 1 (NPR1), a receptor guanylate cyclase known to play a critical role in lowering blood pressure and blood volume.

摘要

该专利着重介绍了氢喹唑啉化合物及其药学上可接受的盐,以及组合物和制备方法。本发明中的化合物针对利钠肽受体1(NPR1)的活性进行了评估,NPR1是一种受体鸟苷酸环化酶,已知在降低血压和血容量方面发挥关键作用。

相似文献

1
Hydroquinazoline Derivatives as Novel Natriuretic Peptide Receptor 1 (NPR1) Activators.作为新型利钠肽受体1(NPR1)激活剂的氢喹唑啉衍生物
ACS Med Chem Lett. 2025 Jan 23;16(3):358-360. doi: 10.1021/acsmedchemlett.5c00013. eCollection 2025 Mar 13.
6
Nitazenes: review of comparative pharmacology and antagonist action.硝氮烯类:比较药理学与拮抗作用综述
Clin Toxicol (Phila). 2025 Jun;63(6):393-406. doi: 10.1080/15563650.2025.2504133. Epub 2025 May 27.

本文引用的文献

1
Cardiac cGMP Regulation and Therapeutic Applications.心脏cGMP调节与治疗应用
Hypertension. 2025 Feb;82(2):185-196. doi: 10.1161/HYPERTENSIONAHA.124.21709. Epub 2024 Dec 11.
2
New and future heart failure drugs.新型及未来的心力衰竭药物。
Nat Cardiovasc Res. 2024 Dec;3(12):1389-1407. doi: 10.1038/s44161-024-00576-z. Epub 2024 Dec 4.
3
C-type natriuretic peptide (CNP): The cardiovascular system and beyond.C 型利钠肽(CNP):心血管系统及其他。
Pharmacol Ther. 2024 Oct;262:108708. doi: 10.1016/j.pharmthera.2024.108708. Epub 2024 Aug 21.
5
New therapeutic targets in hypertension.高血压的新治疗靶点。
Med Clin (Barc). 2024 Sep 27;163(6):301-305. doi: 10.1016/j.medcli.2024.03.028. Epub 2024 Jun 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验